공시 • Dec 29
Regis Announces Appeal of NYSE Determination to Commence Proceedings to Delist Regis' Common Stock Regis Corporation announced that it has requested an oral hearing of the NYSE's decision to commence proceedings to delist Regis' common stock from the New York Stock Exchange ("NYSE"). Regis looks forward to presenting its plan of compliance at the hearing, and in the interim, will continue to evaluate all available listing options. During this time, Regis common stock has not been suspended from trading and is expected to continue to be listed and traded on the NYSE while any such appeal remains pending. However, the NYSE reserves the right, while the appeal remains pending, under subsequent committee review to determine that trading in Regis common stock should be suspended. NYSE Regulation has determined that Regis was unable to demonstrate that it had regained compliance with the applicable listing standard by the expiration of the maximum plan period. As previously disclosed, Regis had been deemed below compliance with the NYSE's continued listing standard in Section 802.01B of the Listed Company Manual requiring listed companies to maintain either (i) at least $50 million in stockholders' equity or (ii) at least $50 million in total market capitalization on a 30-trading day average basis. 공시 • Dec 19
NYSE Regulation Determines to Commence Proceedings to Delist Regis' Common Stock from the NYSE On December 13, 2023, Regis Corporation (the “Company”) received a written notice (the “Notice”) from the staff of NYSE Regulation (the “Staff”) of the New York Stock Exchange (“NYSE”) indicating that the Staff had determined to commence proceedings to delist the common stock of the Company from the NYSE. The Notice indicated that the Staff reached its decision because the Company was unable to demonstrate that it had regained compliance with the applicable listing standard in Section 802.01B of the Listed Company Manual requiring listed companies to maintain either (i) at least $50 million in stockholders’ equity or (ii) at least $50 million in total market capitalization on a 30-trading day average basis. The Company’s common stock has not been suspended from trading and is expected to continue to be listed and traded on the NYSE while any review remains pending. The Company will be appealing the Staff's decision within the required timing and looks forward to presenting its plan of compliance at the hearing. In the interim, the Company will continue to evaluate all available options for maintaining a listing of its common stock on a national securities exchange. The Company has a right to request a review of the Staff’s determination by a Committee of the Board of Directors of the NYSE (the “Committee”). The NYSE would announce a suspension date at such time as (i) the Company does not request a review by the Committee within 10 business days of the Notice, (ii) the Company determines that it does not intend to appeal, (iii) the subsequent review of the Committee determines that the Company should be suspended, or (iv) there are other material developments. After any such suspension announcement, the NYSE would then apply to the Securities and Exchange Commission to delist the Company’s common stock. There can be no assurance of the outcome of any review by the Committee or that the NYSE will reconsider its decision to commence delisting proceedings against the Company in light of such review. 공시 • Dec 15
NYSE to Commence Delisting Proceedings Against Regis Corporation The New York Stock Exchange (“NYSE”, the “Exchange”) announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Regis Corporation (the “Company”) — ticker symbol RGS — from the NYSE. NYSE Regulation has determined that the Company is no longer suitable for listing pursuant to Section 802.02 of the Listed Company Manual as the Company was unable to demonstrate that it had regained compliance with the applicable listing standard by the expiration of the maximum plan period. The Company had previously been deemed below compliance with the NYSE’s continued listing standard in Section 802.01B of the Listed Company Manual requiring listed companies to maintain either (i) at least $50 million in stockholders’ equity or (ii) at least $50 million in total market capitalization on a 30-trading day average basis. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange (the “Committee”). The NYSE will announce a suspension date at such time as i) the Company does not request a review by the Committee within 10 business days of this notice, ii) the Company determines that it does not intend to appeal, iii) the subsequent review of the Committee determines that the Company should be suspended, or iv) there are other material developments. After the suspension announcement, the NYSE would then apply to the Securities and Exchange Commission to delist the common stock. 공시 • Nov 19
Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements Regis Corporation announced that it intends to effect a reverse stock split of its outstanding common stock, par value $0.05 per share, at a ratio of one-for-twenty, with an intended market effective date of November 29, 2023. The reverse stock split is primarily intended to bring the Company into compliance with stock exchange minimum bid price requirements, as the Company explores opportunities to remain listed on a national securities exchange. The reverse stock split is not expected to have a direct impact on the Company’s market capitalization deficiency as previously reported in the Company’s Current Report on Form 8-K filed on June 15, 2022, for which the NYSE-established compliance period is scheduled to end on December 13, 2023. Following the reverse stock split, the Company's common stock will continue to trade under the symbol ‘RGS’. The new CUSIP number for the Company’s common stock following the reverse stock split will be 758932206. Upon the effectiveness of the reverse stock split, every 20 shares of issued and outstanding common stock before the open of trading on November 29, 2023 will be combined into one issued and outstanding share of common stock, with no change in par value per share. The Company’s common stock will open for trading on NYSE on November 29, 2023 on a post-split basis. The reverse stock split will reduce the number of shares of the Company's outstanding common stock from approximately 45.6 million shares to approximately 2.3 million shares. No fractional shares will be issued as a result of the reverse stock split. Any fractional shares that would result from the reverse stock split will be cancelled in exchange for the payment of cash consideration. The reverse stock split will affect all issued and outstanding shares of the Company’s common stock, as well as the number of shares of common stock available for issuance under the Company’s outstanding stock options and stock unit awards. The reverse stock split will reduce the number of shares of common stock issuable upon the exercise of stock options outstanding and the vesting of stock unit awards outstanding immediately prior to the reverse stock split and correspondingly increase the respective exercise prices or other price dependent terms. The reverse stock split will affect all shareholders uniformly and will not alter any shareholder’s percentage interest in the Company’s equity, except to the extent that the reverse stock split results in some shareholders experiencing an adjustment of a fractional share as described above. Shareholders holding share certificates will receive information from EQ Shareowner Services, the Company’s transfer agent, regarding the process for exchanging their shares of common stock. Shareholders with questions may contact our transfer agent by calling 1-800-401-1957. Shareholders owning shares electronically or via a broker, bank, trust or other nominee are expected to have their positions automatically adjusted to reflect the reverse stock split, subject to such broker’s particular processes, and will not be required to take any action in connection with the reverse stock split.